Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 02:17:05 PM Thu, 8 Oct 2020   Contact Information Suhendan Ekmekcioglu Associated Profiles  Professor, Melanoma Medical Oncology, UT MD Anderson Cancer Center     sekmekcioglu@mdanderson.org     713-563-0605    Web Link    Melanoma, Interleukin-24, Neoplasms, Nitric Oxide Synthase Type II, Nitric Oxide, Apoptosis, Cells, Growth    Associated Profiles Professional Preparation Research and Expertise Affiliations Appointments  Professional Preparation  Degree Major Institution Year  PhD Tumor Biology and Immunology University of Istanbul 1993  MS Tumor Biology and Immunology University of Istanbul 1988  BS Biology University of Istanbul 1986  Research and Expertise Research Interests   The major focus of Dr. Suhendan Ekmekcioglu's research is to recognize the inflammatory pathways in melanoma progression. Her early studies revealed that inducible Nitric Oxide Synthase (iNOS) and related pathways are major contributors in melanoma growth by modulating tumor inflammation. These studies further identified tumor-derived inflammation by specific cytokine/chemokine characteristics in tumor microenvironment which drives the process of melanoma progression. As a result of these early discoveries, her research expand the area in collaborating factors, which are the basis of her current scientific interest. Immune modulation strategy for the treatment of melanoma brings a strong hope, specifically, in combinational approaches. Thus, the research projects are designed to overcome melanoma cells' contribution to tumor growth in an inflammatory microenvironment by inhibiting inflammation; and also boosting the immune activators in one cellular cascade, which will give a unique advantage in a clinical setting. The scientific rationale is based on the understanding that all tumor progression is characterized by a complex network of interactions among different cell types that cooperatively exploit a metabolic reprograming and mutually influence their functionality. Arginine metabolism is dependent on the activity within the families of, nitric oxide synthase (NOS) and arginase (ARG) enzymes. Collectively, ARG and NOS enzymes are crucial components of immune suppression pathways, and the metabolic products of these enzymes are important moderators of T-cell function in cancer. Overall, the primary focus in her current research is to determine NO-produce effects on human melanoma cells and microenvironmental T- lymphocytes (TIL) to test the role of NOS driven arginine metabolism on the growth and immune function of the T cells, which will develop a novel area of research.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Research Consortia Gulf Coast Consortia Immunology Cluster  Appointments Title Department / School Institution Professor Melanoma Medical Oncology UT MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.